Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Unity Bancorp
UNTY
$603M
| $552K | ﹤0.01% |
20,201
+6,201
| +44% | +$170K |
|
2902
Corvus Pharmaceuticals
CRVS
$1.17B
| $551K | ﹤0.01% |
648,632
-326,887
| -34% | -$289K |
|
2903
Willamette Valley Vineyards
WVVI
$12M
| $551K | ﹤0.01% |
92,352
-11,400
| -11% | -$69.4K |
|
2904
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $550K | ﹤0.01% |
10,800
-48,800
| -82% | -$2.49M |
|
2905
Enovis
ENOV
$1.51B
| $549K | ﹤0.01% |
+10,267
| New | +$530K |
|
2906
Insmed
INSM
$28.7B
| $545K | ﹤0.01% |
+27,300
| New | +$528K |
|
2907
VanEck Morningstar Wide Moat ETF
MOAT
$12.1B
| $545K | ﹤0.01% |
8,400
-9,600
| -53% | -$623K |
|
2908
American Resources Corp
AREC
$243M
| $544K | ﹤0.01% |
+412,300
| New | +$754K |
|
2909
Citizens
CIA
$231M
| $543K | ﹤0.01% |
254,794
-20,800
| -8% | -$58K |
|
2910
Covenant Logistics
CVLG
$879M
| $543K | ﹤0.01% |
31,400
-65,000
| -67% | -$1.17M |
|
2911
First Western Financial
MYFW
$309M
| $543K | ﹤0.01% |
19,300
-1,700
| -8% | -$47.4K |
|
2912
Invesco Leisure and Entertainment ETF
PEJ
$252M
| $543K | ﹤0.01% |
14,900
-16,600
| -53% | -$621K |
|
2913
Atara Biotherapeutics
ATRA
$74.3M
| $541K | ﹤0.01% |
6,600
-6,844
| -51% | -$713K |
|
|
CFMS
2914
DELISTED
Conformis, Inc. Common Stock
CFMS
| $541K | ﹤0.01% |
163,002
-27,546
| -14% | -$85.5K |
|
2915
iShares Asia 50 ETF
AIA
$4.7B
| $540K | ﹤0.01% |
9,518
-1,282
| -12% | -$68.1K |
|
|
ASM
2916
Avino Silver & Gold Mines
ASM
$1.11B
| $540K | ﹤0.01% |
794,400
+149,970
| +23% | +$96.8K |
|
2917
Century Therapeutics
IPSC
$343M
| $539K | ﹤0.01% |
+105,100
| New | +$992K |
|
2918
McGrath RentCorp
MGRC
$2.97B
| $538K | ﹤0.01% |
+5,447
| New | +$510K |
|
|
ICD
2919
DELISTED
Independence Contract Drilling, Inc.
ICD
| $538K | ﹤0.01% |
164,465
+101,565
| +161% | +$354K |
|
2920
iShares US Regional Banks ETF
IAT
$681M
| $534K | ﹤0.01% |
+11,200
| New | +$550K |
|
2921
ClearOne Inc
CLRO
$26.2M
| $533K | ﹤0.01% |
23,371
-1,120
| -5% | -$14K |
|
2922
3D Systems Corp
DDD
$588M
| $532K | ﹤0.01% |
71,850
-574,401
| -89% | -$5.04M |
|
2923
FVCBankcorp
FVCB
$337M
| $532K | ﹤0.01% |
34,875
+4,500
| +15% | +$70.8K |
|
2924
Biomea Fusion
BMEA
$90.4M
| $531K | ﹤0.01% |
63,000
+1,200
| +2% | +$10.2K |
|
2925
Usio Inc
USIO
$63.7M
| $531K | ﹤0.01% |
321,741
-21,300
| -6% | -$42.6K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.